ICCCライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Stats
本日の出来高	1 776.00
平均出来高	7 173.00
時価総額	39.84M
EPS	$0 ( 2024-02-27 )
次の収益日	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.85
ATR14	$0.0390 (0.76%)

Insider Trading

Date	Person	Action	Amount	type
2023-09-06	Tomsche David Scott	Buy	3 100	Common stock $0.10 per value per share
2023-06-28	Gathagan Bryan K.	Buy	15 000	Non-Qualified Stock Options (Right to buy)
2023-06-16	Gathagan Bryan K.	Buy	0
2023-03-14	Tomsche David Scott	Buy	100	Common Stock, $0.10 per value per share
2023-03-14	Tomsche David Scott	Buy	69	Common Stock, $0.10 per value per share

INSIDER POWER
100.00
Last 96 transactions
Buy: 315 997 \| Sell: 92 686

ImmuCell Corp 相関

10 最も正の相関
SGBX	0.878
VTSI	0.858
CCBG	0.844
FULT	0.843
HAS	0.837
EBMT	0.831
AMSF	0.83
LSBK	0.825
AMTB	0.815
CFB	0.812

10 最も負の相関
TRMD	-0.803

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

ImmuCell Corp 財務諸表

Annual	2023
収益:	$17.47M
総利益:	$3.87M (22.15 %)
EPS:	$-0.750

FY	2023
収益:	$17.47M
総利益:	$3.87M (22.15 %)
EPS:	$-0.750

FY	2022
収益:	$18.57M
総利益:	$7.65M (41.19 %)
EPS:	$-0.320

FY	2021
収益:	$19.24M
総利益:	$8.66M (44.98 %)
EPS:	$-0.0102

Financial Reports:

No articles found.

ImmuCell Corp

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.